Certain ophthalmic subspecialties were more well suited for telemedicine use based on what tends to get covered in patient visits, said Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
Certain ophthalmic subspecialties were more well suited for telemedicine use based on what tends to get covered in patient visits, said Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
Transcript
What can we learn from your study on the utilization of ophthalmic video visits in oculoplastic surgery over time during the pandemic and how these changing levels can predict or inform use post pandemic?
The most valuable piece of information that we learned probably was that there are certain ophthalmic subspecialties that are probably more well suited for telemedicine use. Namely, the 2 that come to mind, and that were presented in our study, were oculoplastic surgery and neuro-ophthalmology.
For oculoplastic surgery, there is more of a reliance on an external examination, rather than the use of a slit lamp or fundoscopy to look at the back of the eye. And so, that lends itself well to high-res video conferencing.
And then, as for neuro-ophthalmology, a lot of the time physicians will spend a lot of time obtaining a great history from the patient, also, an external exam, and also reviewing past imaging and field tests, that none of these things really require in-person visits to accomplish.
So, in those terms, we've learned that over the course of the pandemic that utilizing video visits for these 2 subspecialties are very valuable.
Your study was conducted at an urban care center; what might be concerns with virtual care when moving out to a more rural population and the digital access challenges they might face?
For rural populations, the biggest issue for live video conferencing for telehealth visits would be access to high-speed internet. It's easy with like broadband infrastructure and like gigafiber in urban areas like New York City. But I would suspect that if you venture out into more rural areas, even areas like upstate New York, there's probably a lack of sufficient internet speeds that would make it difficult to conduct live video conferencing with good enough video and audio quality to make ophthalmic care possible.
I think we would also expect that video conferencing software is advanced and perhaps it would be more difficult for older patients in rural areas to adapt to these technologies. But looking at the data that we found, there was not much complaint about the audio or visual quality and difficulty in signing on to conduct these video visits. So, I think that as long as the infrastructure is there, I think that patients will probably adapt very quickly, even in the most rural settings.
Diagnostic Oversights Limit Luspatercept Benefits in MDS
May 8th 2024Investigators of a retrospective study encourage colleagues to utilize molecular testing for patients with an established diagnosis of lower-risk myelodysplastic syndromes (MDS), to be sure they don’t miss out on treatments, like luspatercept, for which they qualify.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More